"Ranolaziodarone"-A Synergism You Should Not Miss
- PMID: 33779663
- PMCID: PMC7987423
- DOI: 10.19102/icrm.2021.120303
"Ranolaziodarone"-A Synergism You Should Not Miss
Keywords: Amiodarone; antiarrhythmic drugs; atrial fibrillation; dronedarone; ranolazine.
Conflict of interest statement
Dr. Reiffel has been an investigator for Medtronic, Janssen, and Sanofi; a consultant for Medtronic, Sanofi, Acesion, Correvio, and Amarin; and has served on a speaker’s bureau for Sanofi within the past 12 months.
Comment on
-
Effects of Ranolazine and its Combination with Amiodarone on Rapid Pacing-induced Reentrant Atrial Tachycardia in Rabbits.J Innov Card Rhythm Manag. 2021 Mar 15;12(3):4421-4427. doi: 10.19102/icrm.2021.120304. eCollection 2021 Mar. J Innov Card Rhythm Manag. 2021. PMID: 33777481 Free PMC article.
References
-
- Giardina EG, Wechsler ME. Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias. J Am Coll Cardiol. 1990;15(5):1138–1145. [CrossRef] [PubMed] - DOI - PubMed
-
- Whitford EG, McGovern B, Schoenfeld MH, et al. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias. Am Heart J. 1988;115(2):360–366. [CrossRef] [PubMed] - DOI - PubMed
-
- Reiffel JA. Going beyond antiarrhythmic-anticoagulant drug interactions: considerations in the complex medicated patient. J Innov Cardiac Rhythm Manage. 2019;10(3):3561–3563. [CrossRef] [PubMed] - DOI - PMC - PubMed
-
- Reiffel JA. Ten pearls for the use of antiarrhythmic drugs for atrial fibrillation. Available at: https://www.acc.org/latest-in-cardiology/articles/2014/07/18/15/12/ten-p.... Accessed December 20, 2020.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources